Invention Grant
- Patent Title: Enhanced solubility drug-containing formulations
-
Application No.: US16609544Application Date: 2018-05-10
-
Publication No.: US11672863B2Publication Date: 2023-06-13
- Inventor: Michael Laird Hurrey , Drazen Ostovic , Peter Noymer
- Applicant: United Therapeutics Corporation
- Applicant Address: US MD Silver Spring
- Assignee: United Therapeutics Corporation
- Current Assignee: United Therapeutics Corporation
- Current Assignee Address: US MD Silver Spring
- Agency: Foley & Lardner LLP
- International Application: PCT/IL2018/050511 2018.05.10
- International Announcement: WO2018/207188A 2018.11.15
- Date entered country: 2019-10-30
- Main IPC: A61K47/12
- IPC: A61K47/12 ; A61K47/02 ; A61P23/02 ; A61K31/445 ; A61K9/00

Abstract:
This invention describes compositions comprising at least 75 mg/mL of solubilized otherwise poorly soluble drug in an aqueous environment, wherein the composition further comprises a combination of 3 or more acids. Methods of providing analgesia, anti-pyretic effects or reducing pain in a subject presenting with a pain condition, and methods of reducing administration site irritation, inflammation or a combination thereof in a subject presenting with a pain condition, comprising the steps of administering such compositions and infusion pumps containing such compositions are also described.
Public/Granted literature
- US20200054754A1 ENHANCED SOLUBILITY DRUG-CONTAINING FORMULATIONS Public/Granted day:2020-02-20
Information query